www.healthline.com

www.healthline.com
Share

www.healthline.com

 •  January 30

The first drug approved to treat BRCA-related breast cancer has limits, but it’s important for women with metastatic disease and BRCA mutation carriers. There’s a new drug to treat one of the tougher types of breast cancer. It’ll buy you about three extra months of what’s called progression-free survival. And it’ll cost you, or your insurance...

www.healthline.com

 •  November 21, 2017

New research shows the average price increase for cancer drugs has risen 37 percent over 12 years. Research costs and high demand are among the reasons. Cancer drug prices seem to defy the laws of economics. They steadily increase regardless of competition, a new study concluded. An international team of researchers tracked the average monthly sale...

www.healthline.com

 •  October 24, 2017

There’s no clear evidence that most new cancer drugs extend or improve life. According to a research team in London, when drugs do show survival gains over other treatments, those gains are often marginal. The researchers looked at reports on cancer approvals by the European Medicines Agency (EMA). Of 68 medications approved by the EMA from 2009 to...

www.healthline.com

 •  October 12, 2017

Pharmaceutical companies are trying to capture a little bit of the startup magic. Pfizer and several other firms have invested in a small spinoff company that will develop drug therapies for underserved patients. With $103 million in initial funding, SpringWorks Therapeutics will focus at first on therapies for post-traumatic stress disorder (PTSD)...

www.healthline.com

 •  October 10, 2017

Maryland has permission to go after prescription drug price gouging. A federal judge gave the go-ahead last week. Drug makers had attempted to block the state’s first-in-the-nation law targeting extreme increases in generic drug prices. The ruling adds Maryland to a growing number of states taking action against high drug prices, as Congress lags...

www.healthline.com

 •  August 16, 2017

To some, Vermont Senator Bernie Sanders may seem like a fading memory from the 2016 presidential campaign. However, this summer, Sanders has been front and center in the battle to lower prescription drug prices. Sanders has been pushing two proposals that he says will help slash the skyrocketing costs of pharmaceutical drugs. One proposal would put...

www.healthline.com

 •  June 6, 2017

There are currently no FDA-approved drugs to treat the core symptoms of autism spectrum disorder (ASD). But new findings published in the Annals of Clinical and Translational Neurology may help open the door to novel treatment options while shedding light on the underlying causes of ASD. In small phase I/II clinical trial at the University of...

www.healthline.com

 •  April 6, 2017

What would you rather lose? Your hair or your ability to perform sexually? It may seem like an obvious choice, but some men may be making that decision without even knowing it. A recent study from Northwestern University has highlighted the need for more information about certain popular drugs targeted at male consumers that inadvertently cause...

www.healthline.com

 •  February 14, 2017

Alternating doses of erythromycin and doxycycline wiped out E. coli bacteria thought to be resistant to both drugs. Finally, there’s some good news about the rise of antibiotic-resistant bacteria. Bacteria are developing tolerance to nearly all of the antibiotics in modern medicine’s bag, threatening to plunge us back to a time when common...